Strategy Notes
The EIC Accelerator is a strong fit for the venture's breakthrough deep tech in AI-driven drug resistance prediction, offering substantial non-dilutive funding and equity. The venture's pre-seed stage and validated proof-of-concept align with EIC's support for high-risk, innovative SMEs, though incorporation is required before applying.